INHIBITION OF HERPES SIMPLEX VIRUS TYPE 1 BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1
The DOI matches its Crossref record.
Abstract
BACKGROUND: Despite advances in antiviral chemotherapy, herpes simplex virus type 1 (HSV-1), continues to complicate the clinical course of many allograft recipients. We have previously demonstrated that the experimental immunosuppressive agent leflunomide inhibits production of cytomegalovirus by interference with virion assembly. We test the hypothesis that this agent exerts similar antiviral activity against HSV-1. METHODS AND RESULTS: Plaque assay of virus yield from endothelial or Vero cells after inoculation with each of four clinical HSV-1 isolates demonstrated a dose-dependent reduction of virus production in the presence of pharmacologic concentrations of A77 1726, the active metabolite of leflunomide. DNA dot blot and biochemical assay of viral DNA polymerase activity indicated that A77 does not inhibit viral DNA synthesis. Rather, as visualized by transmission electron microscopic method, this agent seems to disrupt virion assembly by preventing nucleocapsid tegumentation. CONCLUSIONS: These findings, in demonstrating that leflunomide exerts antiviral activity against HSV-1 by mechanisms similar to those we have previously shown with cytomegalovirus, imply that this agent may possess broad spectrum activity against other herpesviruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tait, B. D., Süsal, C., Gebel, H. M., Nickerson, P. W., Zachary, A. A., Claas, F. H. J., Reed, E. F., Bray, R. A., Campbell, P., Chapman, J. R., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e31827a19cc · Cited by 787
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis
Hoffmann, H.-H., Kunz, A., Simon, V. A., Palese, P., & Shaw, M. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101143108 · Cited by 266
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
Perricone, C., Triggianese, P., Bartoloni, E., Cafaro, G., Bonifacio, A. F., Bursi, R., Perricone, R., & Gerli, R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102468 · Cited by 159
“LEF reduces the in vitro spreading of CMV and HSV-1 infection by interfering with virion cytoplasmatic assembly in a dosedependent manner [107, 108] .”
A comprehensive review of immunosuppression used for liver transplantation
Mukherjee, S., & Mukherjee, U. (2009) · Journal of Transplantation · doi:10.1155/2009/701464 · Cited by 140
Enose-Akahata, Y., Ngouth, N., Ohayon, J., Mandel, M., Chavin, J., Turner, T. J., & Jacobson, S. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000986 · Cited by 13
Metadata
- Authors
- Knight, D. A., Hejmanowski, A. Q., Dierksheide, J. E., Williams, J. W., Chong, A. S.-F., & Waldman, W. J.
- Venue
- Transplantation
- Published
- 2001-01
- Volume
- 71
- Issue
- 1
- Pages
- 170-174
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2022290790
- Cited by
- 99
- References
- 0
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: INHIBITION OF HERPES SIMPLEX VIRUS TYPE 1 BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1. https://app.cochat.ai/papers/10.1097/00007890-200101150-00031
- The paper
- Knight, D. A., Hejmanowski, A. Q., Dierksheide, J. E., Williams, J. W., Chong, A. S.-F., & Waldman, W. J. (2001). INHIBITION OF HERPES SIMPLEX VIRUS TYPE 1 BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1. Transplantation. https://doi.org/10.1097/00007890-200101150-00031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.